Classification and recent update in renal glomerular lesions/ glomerulonephritis immunofluorescense for md pathology exam
glomerulonephritis immunofluorescence classification update
glomerulonephritis classification pathology update
IgA nephropathy mesangial deposits immunofluorescence

This diagnostic image shows a renal biopsy specimen analyzed via direct immunofluorescence (DIF). The central feature is a glomerulus exhibiting intense, bright green fluorescence against a dark background. The fluorescence displays a characteristic granular pattern, localized predominantly within the mesangium (mesangial distribution). These granular deposits are irregular in size and shape, effectively outlining the branching structures of the glomerular tuft. This specific immunopathological finding is diagnostic for IgA nephropathy, representing the deposition of IgA-containing immune complexes in the renal mesangial areas. The surrounding renal parenchyma shows minimal non-specific background fluorescence. This visual is representative of Haas class III IgA nephropathy, typically associated with hematuria and significant proteinuria.

This diagnostic immunofluorescence image demonstrates a renal glomerulus exhibiting a characteristic staining pattern for IgA nephropathy. Against a dark background, a bright green fluorescent signal is localized primarily within the mesangial regions. The signal presents as granular, irregular deposits concentrated in the mesangial matrix, reflecting the entrapment of immunoglobulin A (IgA) immune complexes. The overall structure of the glomerulus shows a complex, lobulated architecture with visible capillary loops. While some areas demonstrate intense, discrete granular fluorescence, others show a more diffuse or attenuated signal, which may correlate with underlying morphological changes such as mesangial hypercellularity or segmental sclerosis. This imaging modality is essential in nephropathology for differentiating between various forms of glomerulonephritis based on the specific distribution (mesangial vs. capillary wall) and nature (granular vs. linear) of immune deposits.

This diagnostic image is a high-magnification (x400) immunofluorescence microscopy of a renal biopsy specimen. The visual field demonstrates a single glomerulus exhibiting a classic pathological pattern of intense, apple-green fluorescent staining. The primary finding is the global, 3+ intensity mesangial deposition of immunoglobulin A (IgA). The deposits are characterized by a granular and confluent distribution primarily restricted to the mesangial matrix and stalk regions of the glomerular tuft, highlighting the branched architecture of the mesangium. There is a notable absence of significant capillary loop or basement membrane staining, which is highly characteristic of IgA nephropathy (Berger disease). The surrounding renal parenchyma is dark, providing high contrast to the localized immunocomplex accumulation within the glomerular architecture. This diagnostic finding is a hallmark educational example used to confirm the diagnosis of primary IgA nephropathy or Henoch-Schönlein purpura nephritis in clinical pathology.
membranous nephropathy granular subepithelial deposits immunofluorescence

This diagnostic image is a high-power (400x) immunofluorescence micrograph of a human glomerulus from a renal biopsy specimen. The image demonstrates a diffuse, granular staining pattern of 3+ intensity, specifically localized along the glomerular capillary loops. The green fluorescent signal highlights the convoluted, interconnected morphology of the basement membrane area in a 'beaded' fashion, which is characteristic of immune complex deposition. Pathologically, this visual finding represents positive staining for phospholipase A2 receptor (PLA2R) antibodies, a definitive diagnostic marker for primary membranous nephropathy. The absence of mesangial or endocapillary staining emphasizes the subepithelial nature of the deposits. This specimen is critical for differentiating primary autoimmune-mediated glomerular disease from secondary causes in patients presenting with nephrotic syndrome.

This composite of confocal light microscopy images illustrates immunofluorescence staining patterns in human glomerular tissue, specifically focusing on membranous nephropathy (MN). The 20-panel figure is organized into five rows (A-T), each representing a different IgG target: total IgG, IgG1, IgG2, IgG3, and IgG4. Within each row, four panels show: (1) DAPI nuclear staining in blue, (2) IgG or specific IgG subclasses in green, (3) PLA2R antigen in red, and (4) a merged overlay. The staining reveals a granular, loop-like distribution along the glomerular basement membrane (GBM), characteristic of subepithelial immune complex deposits. In the merged columns (D, H, L, P, T), the overlap of green (IgG) and red (PLA2R) signals produces a yellow color, demonstrating the co-localization of the PLA2R antigen with total IgG and all four IgG subclasses. DAPI staining confirms that these deposits are extracellular and distinct from cellular nuclei. This visual evidence supports the role of PLA2R as a major autoantigen in primary MN and characterizes the subclass composition of the associated immune deposits.
| Term | Definition |
|---|---|
| Diffuse | >50% of all glomeruli affected |
| Focal | <50% of glomeruli affected |
| Global | Entire glomerulus involved |
| Segmental | Only part of a glomerulus involved |
| Proliferative | Increase in number of cells (mesangial, endothelial, epithelial) |
| Membranous | Basement membrane thickening without proliferation |
| Membranoproliferative | Both BM thickening + proliferation |
| Crescentic | Epithelial cell proliferation in Bowman space forming crescents |
| Sclerosing | Collagenous obliteration of glomerular loops |
| Syndrome | Hallmarks | Prototypic Disease |
|---|---|---|
| Nephritic | Hematuria, RBC casts, hypertension, oliguria, mild proteinuria | Post-infectious GN, Crescentic GN |
| Nephrotic | Massive proteinuria (>3.5 g/day), hypoalbuminemia, edema, hyperlipidemia, lipiduria | Membranous nephropathy, MCD, FSGS |
| Nephritic-Nephrotic | Overlap features | MPGN, Diffuse Proliferative Lupus GN |
| Asymptomatic hematuria | Microscopic hematuria ± mild proteinuria | IgA nephropathy |
| RPGN | Rapid loss of renal function over weeks-months, crescents | Anti-GBM, ANCA-vasculitis |

| Disease | LM | IF Pattern | IF Immunoreactants | EM |
|---|---|---|---|---|
| Post-infectious GN | Diffuse endocapillary proliferation, "starry sky" | Granular | IgG + C3 in GBM and mesangium; "lumpy-bumpy" | Subepithelial humps (hallmark) |
| Crescentic (RPGN) - Type I (Anti-GBM) | Crescents, fibrinoid necrosis | LINEAR | IgG (linear) + C3 along GBM | No deposits |
| Crescentic (RPGN) - Type II (Immune complex) | Crescents + proliferation | Granular | IgG + C3 ± IgM, IgA | Immune complex deposits at various sites |
| Crescentic (RPGN) - Type III (ANCA) | Crescents, necrosis | Pauci-immune (negative) | No deposits (or trace) | No deposits |
| Membranous Nephropathy | Diffuse GBM thickening; "spike and dome" (silver stain) | Granular capillary wall | IgG + C3 (diffuse granular along capillary loops) | Subepithelial deposits; GBM spikes |
| Minimal Change Disease (MCD) | Normal (lipid in tubules) | Negative or faint IgM | Usually negative; fine granular podocyte IgG (anti-nephrin) in most recent update | Effacement of foot processes; NO deposits |
| FSGS | Focal segmental sclerosis + hyalinosis | IgM + C3 (segmental) | Nonspecific IgM and C3 trapped in sclerosed segments | Foot process effacement; epithelial denudation |
| MPGN Type I | Mesangial proliferation + GBM thickening + "tram-track" (double contour) | Granular | IgG + C3; C1q + C4 (classical pathway activation) | Subendothelial deposits |
| Dense Deposit Disease (C3G / MPGN Type II) | Tram-track; ribbon-like dense deposits | C3 only (no C1q, no C4, no Ig) | C3 dominant - alternative pathway dysregulation | Extremely dense, ribbon-like intramembranous deposits |
| C3 Glomerulonephritis (C3GN) | Variable (mesangial to MPGN pattern) | C3 dominant (C3 ≥ 2 orders more than any Ig) | C3 only or dominant | Mesangial/subendothelial/subepithelial deposits |
| IgA Nephropathy (Berger disease) | Focal mesangial proliferative GN | Mesangial granular | Dominant IgA + C3 in mesangium ± IgG, IgM | Mesangial and paramesangial deposits |
| Lupus Nephritis (Class III/IV) | Proliferative GN; "wire loops" | "Full house" | IgG + IgA + IgM + C3 + C1q (all positive = "full house") | Subendothelial + subepithelial + mesangial deposits; tubuloreticular inclusions |
| Fibrillary GN | Mesangial expansion; MPGN pattern | Granular | IgG (dominant IgG4) + C3; DNAJB9 positive (diagnostic marker) | Fibrils 20 nm diameter (larger than amyloid) |
| Immunotactoid GN | Similar to Fibrillary GN | Granular | IgG (monoclonal) | Microtubules 30-50 nm diameter |


| Type | Mechanism | IF | Serology |
|---|---|---|---|
| Type I - Anti-GBM | Anti-NC1 (Type IV collagen) antibodies | Linear IgG + C3 | Anti-GBM antibody positive |
| Type II - Immune Complex | Circulating/in situ IC deposition | Granular IgG ± C3 | Low complement, variable serology |
| Type III - Pauci-immune (ANCA) | Neutrophil-mediated, no IC | Negative (pauci-immune) | c-ANCA (PR3) or p-ANCA (MPO) positive |
| Type IV | Combined anti-GBM + ANCA | Linear + positive ANCA | Both anti-GBM and ANCA positive |
| Class | Pathology | IF |
|---|---|---|
| I | Minimal mesangial | Normal or minimal mesangial deposits |
| II | Mesangial proliferative | Mesangial IgG/IgA/IgM/C3/C1q |
| III | Focal proliferative (<50% glomeruli) | Segmental "full house" IF |
| IV | Diffuse proliferative (>50% glomeruli) | Diffuse "full house" IF; wire loops |
| V | Membranous (may co-exist with III/IV) | Granular capillary IF ("full house") |
| VI | Advanced sclerosing (>90% global sclerosis) | Absent/minimal IF |
| Antigen | Association | IF/Lab Finding |
|---|---|---|
| PLA2R (phospholipase A2 receptor) | Primary MN (~70-80%) | IgG4 dominant; serum anti-PLA2R antibody |
| THSD7A (thrombospondin domain 7A) | Primary MN (~3-5%) | IgG4 dominant |
| NELL1 (Neural epidermal growth factor-like 1) | Primary MN (older males, ~15-20%) | IgG1 dominant |
| EXT1/EXT2 (Exostosin 1/2) | Autoimmune-associated (lupus, SLE-associated MN) | IgG1/IgG2 dominant |
| NCAM1 (Neural cell adhesion molecule 1) | Primary MN | IgG1 dominant |
| IF Pattern | Think Of |
|---|---|
| Linear IgG + C3 | Anti-GBM (Goodpasture) |
| Granular IgG + C3 (GBM + mesangium) | Post-infectious GN |
| Granular IgG + C3 (capillary wall only) | Membranous nephropathy |
| Dominant IgA (mesangial) | IgA nephropathy / HSP |
| C3 only (no Ig) | C3 Glomerulopathy (DDD or C3GN) |
| IgG + C3 + C1q + C4 | MPGN Type I (immune complex) |
| Full house (IgG+IgA+IgM+C3+C1q) | Lupus nephritis |
| Negative / Pauci-immune | ANCA vasculitis |
| IgM + C3 (segmental) | FSGS (nonspecific entrapment) |
| Congo red + amyloid P | Amyloidosis (apple-green birefringence) |
| IgG (monoclonal) - microtubules 30-50nm | Immunotactoid GN |
| IgG + DNAJB9 (fibrils 20nm) | Fibrillary GN |
| Location | Associated Disease |
|---|---|
| Subepithelial humps | Post-infectious GN (characteristic) |
| Subepithelial spikes | Membranous nephropathy |
| Subendothelial deposits | MPGN Type I, Lupus (Class III/IV) |
| Mesangial deposits | IgA nephropathy, Lupus Class II |
| Intramembranous (dense) | Dense Deposit Disease (C3G-DDD) |
| Foot process effacement only (no deposits) | MCD, early FSGS |
| Tubuloreticular inclusions (endothelium) | Lupus nephritis (interferon signature) |
| Fibrils 10-12nm (randomly arranged) | Amyloidosis |
| Fibrils 20nm | Fibrillary GN |
| Microtubules 30-50nm | Immunotactoid GN |